Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer.

Ganapathy K, Staklinski S, Hasan MF, Ottman R, Andl T, Berglund AE, Park JY, Chakrabarti R.

Sci Rep. 2020 Mar 20;10(1):5167. doi: 10.1038/s41598-020-62038-3.

2.

Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy.

Garg SK, Ott MJ, Mostofa AGM, Chen Z, Chen YA, Kroeger J, Cao B, Mailloux AW, Agrawal A, Schaible BJ, Sarnaik A, Weber JS, Berglund AE, Mulé JJ, Markowitz J.

Front Immunol. 2020 Feb 25;11:164. doi: 10.3389/fimmu.2020.00164. eCollection 2020.

3.

Expression of the BAD pathway is a marker of triple-negative status and poor outcome.

Boac BM, Abbasi F, Ismail-Khan R, Xiong Y, Siddique A, Park H, Han M, Saeed-Vafa D, Soliman H, Henry B, Pena MJ, McClung EC, Robertson SE, Todd SL, Lopez A, Sun W, Apuri S, Lancaster JM, Berglund AE, Magliocco AM, Marchion DC.

Sci Rep. 2019 Nov 25;9(1):17496. doi: 10.1038/s41598-019-53695-0.

4.

Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk.

Creed JH, Berglund AE, Rounbehler RJ, Awasthi S, Cleveland JL, Park JY, Yamoah K, Gerke TA.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):246-253. doi: 10.1158/1055-9965.EPI-19-0407. Epub 2019 Nov 22.

PMID:
31757784
5.

Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma.

Wu Q, Berglund AE, Wang D, MacAulay RJ, Mulé JJ, Etame AB.

Sci Rep. 2019 Oct 1;9(1):14072. doi: 10.1038/s41598-019-50489-2.

6.

African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.

Echevarria MI, Awasthi S, Cheng CH, Berglund AE, Rounbehler RJ, Gerke TA, Takhar M, Davicioni E, Klein EA, Freedland SJ, Ross AE, Schaeffer EM, Den RB, Cleveland JL, Park JY, Rayford W, Yamoah K.

J Urol. 2019 Aug;202(2):247-255. doi: 10.1097/JU.0000000000000193. Epub 2019 Jul 8.

PMID:
31107158
7.

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.

Berglund AE, Rounbehler RJ, Gerke T, Awasthi S, Cheng CH, Takhar M, Davicioni E, Alshalalfa M, Erho N, Klein EA, Freedland SJ, Ross AE, Schaeffer EM, Trock BJ, Den RB, Cleveland JL, Park JY, Dhillon J, Yamoah K.

Prostate Cancer Prostatic Dis. 2019 May;22(2):292-302. doi: 10.1038/s41391-018-0103-4. Epub 2018 Oct 26.

8.

Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer.

Rounbehler RJ, Berglund AE, Gerke T, Takhar MM, Awasthi S, Li W, Davicioni E, Erho NG, Ross AE, Schaeffer EM, Klein EA, Karnes RJ, Jenkins RB, Cleveland JL, Park JY, Yamoah K.

Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1376-1383. doi: 10.1158/1055-9965.EPI-18-0369. Epub 2018 Aug 14.

9.

Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line.

Zhu G, Nemoto S, Mailloux AW, Perez-Villarroel P, Nakagawa R, Falahat R, Berglund AE, Mulé JJ.

Front Immunol. 2018 Jul 16;9:1609. doi: 10.3389/fimmu.2018.01609. eCollection 2018.

10.

Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose.

Ahmed KA, Scott JG, Arrington JA, Naghavi AO, Grass GD, Perez BA, Caudell JJ, Berglund AE, Welsh EA, Eschrich SA, Dilling TJ, Torres-Roca JF.

J Thorac Oncol. 2018 Aug;13(8):1121-1127. doi: 10.1016/j.jtho.2018.04.027. Epub 2018 May 5.

11.

Evaluating somatic tumor mutation detection without matched normal samples.

Teer JK, Zhang Y, Chen L, Welsh EA, Cress WD, Eschrich SA, Berglund AE.

Hum Genomics. 2017 Sep 4;11(1):22. doi: 10.1186/s40246-017-0118-2.

12.

BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.

Wang D, Berglund AE, Kenchappa RS, MacAulay RJ, Mulé JJ, Etame AB.

Sci Rep. 2017 Aug 24;7(1):9350. doi: 10.1038/s41598-017-09503-8.

13.

Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes.

Prabhakaran S, Rizk VT, Ma Z, Cheng CH, Berglund AE, Coppola D, Khalil F, Mulé JJ, Soliman HH.

Breast Cancer Res. 2017 Jun 19;19(1):71. doi: 10.1186/s13058-017-0864-z.

14.

The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity.

Ahmed KA, Berglund AE, Welsh EA, Naghavi AO, Kim Y, Yu M, Robinson TJ, Eschrich SA, Johnstone PAS, Torres-Roca JF.

Neuro Oncol. 2017 Aug 1;19(8):1145-1146. doi: 10.1093/neuonc/nox043. No abstract available.

15.

Characteristics and Validation Techniques for PCA-Based Gene-Expression Signatures.

Berglund AE, Welsh EA, Eschrich SA.

Int J Genomics. 2017;2017:2354564. doi: 10.1155/2017/2354564. Epub 2017 Feb 6.

16.

Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.

Berglund AE, Scott KE, Li W, Yang C, Fernandez MR, Schaub FX, Cleveland JL, Rounbehler RJ.

Oncotarget. 2016 Dec 13;7(50):83462-83475. doi: 10.18632/oncotarget.13128.

17.

Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.

Ahmed KA, Caudell JJ, El-Haddad G, Berglund AE, Welsh EA, Yue B, Hoffe SE, Naghavi AO, Abuodeh YA, Frakes JM, Eschrich SA, Torres-Roca JF.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1399-1404. doi: 10.1016/j.ijrobp.2016.03.050. Epub 2016 Apr 8.

PMID:
27319288
18.

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.

Bush SH, Tollin S, Marchion DC, Xiong Y, Abbasi F, Ramirez IJ, Zgheib NB, Boac B, Judson PL, Chon HS, Wenham RM, Apte SM, Cubitt CL, Berglund AE, Havrilesky LJ, Lancaster JM.

Mol Clin Oncol. 2016 Mar;4(3):399-404. Epub 2016 Jan 7.

19.

Clinical Significance of p53 and p16(ink4a) Status in a Contemporary North American Penile Carcinoma Cohort.

Zargar-Shoshtari K, Spiess PE, Berglund AE, Sharma P, Powsang JM, Giuliano A, Magliocco AM, Dhillon J.

Clin Genitourin Cancer. 2016 Aug;14(4):346-51. doi: 10.1016/j.clgc.2015.12.019. Epub 2015 Dec 23.

PMID:
26794389
20.

Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.

Boac BM, Xiong Y, Marchion DC, Abbasi F, Bush SH, Ramirez IJ, Khulpateea BR, Clair McClung E, Berry AL, Bou Zgheib N, Chon HS, Shahzad MM, Judson PL, Wenham RM, Apte SM, Berglund AE, Magliocco AM, Lancaster JM.

Gynecol Oncol. 2016 Feb;140(2):259-63. doi: 10.1016/j.ygyno.2015.12.026. Epub 2015 Dec 28.

21.

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma.

Schabath MB, Welsh EA, Fulp WJ, Chen L, Teer JK, Thompson ZJ, Engel BE, Xie M, Berglund AE, Creelan BC, Antonia SJ, Gray JE, Eschrich SA, Chen DT, Cress WD, Haura EB, Beg AA.

Oncogene. 2016 Jun 16;35(24):3209-16. doi: 10.1038/onc.2015.375. Epub 2015 Oct 19.

22.

Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.

Wang H, Schabath MB, Liu Y, Berglund AE, Bloom GC, Kim J, Stringfield O, Eikman EA, Klippenstein DL, Heine JJ, Eschrich SA, Ye Z, Gillies RJ.

Clin Lung Cancer. 2015 Nov;16(6):e141-63. doi: 10.1016/j.cllc.2015.05.007. Epub 2015 May 27.

23.

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.

Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE, Dilling TJ, Eschrich SA, Shridhar R, Torres-Roca JF.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):837-42. doi: 10.1016/j.ijrobp.2015.01.036. Epub 2015 Mar 30.

24.

Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma.

Grove O, Berglund AE, Schabath MB, Aerts HJ, Dekker A, Wang H, Velazquez ER, Lambin P, Gu Y, Balagurunathan Y, Eikman E, Gatenby RA, Eschrich S, Gillies RJ.

PLoS One. 2015 Mar 4;10(3):e0118261. doi: 10.1371/journal.pone.0118261. eCollection 2015.

25.

BAD-mediated apoptotic pathway is associated with human cancer development.

Stickles XB, Marchion DC, Bicaku E, Al Sawah E, Abbasi F, Xiong Y, Bou Zgheib N, Boac BM, Orr BC, Judson PL, Berry A, Hakam A, Wenham RM, Apte SM, Berglund AE, Lancaster JM.

Int J Mol Med. 2015 Apr;35(4):1081-7. doi: 10.3892/ijmm.2015.2091. Epub 2015 Feb 5.

26.

Expanding epigenomics to archived FFPE tissues: an evaluation of DNA repair methodologies.

Siegel EM, Berglund AE, Riggs BM, Eschrich SA, Putney RM, Ajidahun AO, Coppola D, Shibata D.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2622-31. doi: 10.1158/1055-9965.EPI-14-0464.

27.

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.

Marchion DC, Xiong Y, Chon HS, Al Sawah E, Bou Zgheib N, Ramirez IJ, Abbasi F, Stickles XB, Judson PL, Hakam A, Gonzalez-Bosquet J, Wenham RM, Apte SM, Berglund AE, Lancaster JM.

Am J Obstet Gynecol. 2013 Dec;209(6):576.e1-576.e16. doi: 10.1016/j.ajog.2013.08.004. Epub 2013 Aug 9.

28.

Iterative rank-order normalization of gene expression microarray data.

Welsh EA, Eschrich SA, Berglund AE, Fenstermacher DA.

BMC Bioinformatics. 2013 May 7;14:153. doi: 10.1186/1471-2105-14-153.

29.

12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

Messina JL, Fenstermacher DA, Eschrich S, Qu X, Berglund AE, Lloyd MC, Schell MJ, Sondak VK, Weber JS, Mulé JJ.

Sci Rep. 2012;2:765. doi: 10.1038/srep00765. Epub 2012 Oct 24.

30.

Informatics methods to enable sharing of quantitative imaging research data.

Levy MA, Freymann JB, Kirby JS, Fedorov A, Fennessy FM, Eschrich SA, Berglund AE, Fenstermacher DA, Tan Y, Guo X, Casavant TL, Brown BJ, Braun TA, Dekker A, Roelofs E, Mountz JM, Boada F, Laymon C, Oborski M, Rubin DL.

Magn Reson Imaging. 2012 Nov;30(9):1249-56. doi: 10.1016/j.mri.2012.04.007. Epub 2012 Jul 6.

31.

PZIM: a method for similarity searching using atom environments and 2D alignment.

Berglund AE, Head RD.

J Chem Inf Model. 2010 Oct 25;50(10):1790-5. doi: 10.1021/ci1002075.

PMID:
20886834

Supplemental Content

Loading ...
Support Center